pubmed-article:18645192 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18645192 | lifeskim:mentions | umls-concept:C1332399 | lld:lifeskim |
pubmed-article:18645192 | lifeskim:mentions | umls-concept:C0280803 | lld:lifeskim |
pubmed-article:18645192 | lifeskim:mentions | umls-concept:C1332223 | lld:lifeskim |
pubmed-article:18645192 | lifeskim:mentions | umls-concept:C1517986 | lld:lifeskim |
pubmed-article:18645192 | lifeskim:mentions | umls-concept:C1511695 | lld:lifeskim |
pubmed-article:18645192 | lifeskim:mentions | umls-concept:C0021212 | lld:lifeskim |
pubmed-article:18645192 | pubmed:issue | 29 | lld:pubmed |
pubmed-article:18645192 | pubmed:dateCreated | 2008-10-9 | lld:pubmed |
pubmed-article:18645192 | pubmed:abstractText | Primary CNS lymphoma (PCNSL) is an aggressive lymphoma but clinically validated biologic markers that can predict natural history to tailor treatment according to risk are lacking. Several genetic changes including BCL6 rearrangements and deletion of 6q22, containing the putative tumor suppressor gene PTPRK, are potential risk predictors. Herein we determined the prevalence and survival impact of del(6)(q22) and BCL6, immunoglobulin heavy chain (IGH), and MYC gene rearrangements in a large PCNSL cohort treated in a single center. | lld:pubmed |
pubmed-article:18645192 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:language | eng | lld:pubmed |
pubmed-article:18645192 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18645192 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18645192 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18645192 | pubmed:month | Oct | lld:pubmed |
pubmed-article:18645192 | pubmed:issn | 1527-7755 | lld:pubmed |
pubmed-article:18645192 | pubmed:author | pubmed-author:DoganAhmetA | lld:pubmed |
pubmed-article:18645192 | pubmed:author | pubmed-author:KurtinPaul... | lld:pubmed |
pubmed-article:18645192 | pubmed:author | pubmed-author:DeckerPaul... | lld:pubmed |
pubmed-article:18645192 | pubmed:author | pubmed-author:GianniniCater... | lld:pubmed |
pubmed-article:18645192 | pubmed:author | pubmed-author:RemsteinEllen... | lld:pubmed |
pubmed-article:18645192 | pubmed:author | pubmed-author:O'NeillBrian... | lld:pubmed |
pubmed-article:18645192 | pubmed:author | pubmed-author:LawMark EME | lld:pubmed |
pubmed-article:18645192 | pubmed:author | pubmed-author:CadyFrancois... | lld:pubmed |
pubmed-article:18645192 | pubmed:author | pubmed-author:JohnstonPatri... | lld:pubmed |
pubmed-article:18645192 | pubmed:author | pubmed-author:KurtzDavid... | lld:pubmed |
pubmed-article:18645192 | pubmed:author | pubmed-author:PorterAlyx... | lld:pubmed |
pubmed-article:18645192 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18645192 | pubmed:day | 10 | lld:pubmed |
pubmed-article:18645192 | pubmed:volume | 26 | lld:pubmed |
pubmed-article:18645192 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18645192 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18645192 | pubmed:pagination | 4814-9 | lld:pubmed |
pubmed-article:18645192 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
pubmed-article:18645192 | pubmed:meshHeading | pubmed-meshheading:18645192... | lld:pubmed |
pubmed-article:18645192 | pubmed:meshHeading | pubmed-meshheading:18645192... | lld:pubmed |
pubmed-article:18645192 | pubmed:meshHeading | pubmed-meshheading:18645192... | lld:pubmed |
pubmed-article:18645192 | pubmed:meshHeading | pubmed-meshheading:18645192... | lld:pubmed |
pubmed-article:18645192 | pubmed:meshHeading | pubmed-meshheading:18645192... | lld:pubmed |
pubmed-article:18645192 | pubmed:meshHeading | pubmed-meshheading:18645192... | lld:pubmed |
pubmed-article:18645192 | pubmed:meshHeading | pubmed-meshheading:18645192... | lld:pubmed |
pubmed-article:18645192 | pubmed:meshHeading | pubmed-meshheading:18645192... | lld:pubmed |
pubmed-article:18645192 | pubmed:meshHeading | pubmed-meshheading:18645192... | lld:pubmed |
pubmed-article:18645192 | pubmed:meshHeading | pubmed-meshheading:18645192... | lld:pubmed |
pubmed-article:18645192 | pubmed:meshHeading | pubmed-meshheading:18645192... | lld:pubmed |
pubmed-article:18645192 | pubmed:meshHeading | pubmed-meshheading:18645192... | lld:pubmed |
pubmed-article:18645192 | pubmed:meshHeading | pubmed-meshheading:18645192... | lld:pubmed |
pubmed-article:18645192 | pubmed:meshHeading | pubmed-meshheading:18645192... | lld:pubmed |
pubmed-article:18645192 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18645192 | pubmed:articleTitle | Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course. | lld:pubmed |
pubmed-article:18645192 | pubmed:affiliation | Department of Pathology, CellNetix Pathology, Olympia, WA, USA. | lld:pubmed |
pubmed-article:18645192 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18645192 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |